Charles Jameson

University College Hospital, University College London

Papers

3

Total Citations

54

H-Index

3

About

Charles Jameson is a surgical oncologist and translational researcher whose work centers on improving outcomes for men with prostate cancer through intraoperative precision and tissue-based research. His major contributions lie in the development and clinical evaluation of real-time surgical margin assessment techniques. He led the NeuroSAFE PROOF feasibility randomized controlled trial (2020, 46 citations), which established the peri-operative and histopathological concordance of the NeuroSAFE frozen section technique during robot-assisted radical prostatectomy, paving the way for reduced positive margin rates. Jameson also pioneered the PEOPLE pathway (2019, 4 citations), a novel tissue collection protocol that uses MRI data to target both tumor and benign tissue in fresh prostate specimens, enabling high-quality research samples. His earlier work on Cerenkov Luminescence Imaging (2015, 4 citations) explored optical intraoperative margin detection. Together, these studies demonstrate Jameson’s commitment to bridging surgical innovation with tissue-based discovery, directly impacting surgical decision-making and the quality of prostate cancer research.

Research Focus

Key Achievements

3
H-Index
3
Papers
54
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
NeuroSAFE frozen section during robot‐assisted radical prostatectomy: peri‐operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial
46 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: University College Hospital, University College London

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago